May 26 (Reuters) - Nantahala Capital Management:
* NANTAHALA CAPITAL MANAGEMENT, LLC REPORTS 7.2% STAKE IN
AYTU
BIOPHARMA COMMON STOCK AS OF MAY 26, 2023 - SEC FILING
* NANTAHALA CAPITAL MANAGEMENT: BOUGHT AYTU BIOPHARMA SHARES
BASED
ON BELIEF THAT THEY WERE UNDERVALUED, REPRESENTED ATTRACTIVE
INVESTMENT OPPORTUNITY
* NANTAHALA CAPITAL MANAGEMENT: HAVE BEEN INVITED TO
DISCUSSIONS
REGARDING MEANS TO PRESERVE AND ENHANCE SHAREHOLDER VALUE WITH
AYTU BIOPHARMA BOARD
Further company coverage: AYTU.O
((Reuters.Briefs@thomsonreuters.com;))